7-65967580-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000181.4(GUSB):c.1653+151A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.565 in 718,606 control chromosomes in the GnomAD database, including 118,645 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.51 ( 20730 hom., cov: 32)
Exomes 𝑓: 0.58 ( 97915 hom. )
Consequence
GUSB
NM_000181.4 intron
NM_000181.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.05
Genes affected
GUSB (HGNC:4696): (glucuronidase beta) This gene encodes a hydrolase that degrades glycosaminoglycans, including heparan sulfate, dermatan sulfate, and chondroitin-4,6-sulfate. The enzyme forms a homotetramer that is localized to the lysosome. Mutations in this gene result in mucopolysaccharidosis type VII. Alternative splicing results in multiple transcript variants. There are many pseudogenes of this locus in the human genome.[provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 7-65967580-T-C is Benign according to our data. Variant chr7-65967580-T-C is described in ClinVar as [Benign]. Clinvar id is 528232.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.787 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.508 AC: 77219AN: 151906Hom.: 20718 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
77219
AN:
151906
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.580 AC: 328406AN: 566582Hom.: 97915 AF XY: 0.582 AC XY: 178612AN XY: 306878 show subpopulations
GnomAD4 exome
AF:
AC:
328406
AN:
566582
Hom.:
AF XY:
AC XY:
178612
AN XY:
306878
show subpopulations
African (AFR)
AF:
AC:
5511
AN:
16336
American (AMR)
AF:
AC:
19152
AN:
35264
Ashkenazi Jewish (ASJ)
AF:
AC:
12294
AN:
19460
East Asian (EAS)
AF:
AC:
27935
AN:
32024
South Asian (SAS)
AF:
AC:
39748
AN:
64322
European-Finnish (FIN)
AF:
AC:
21201
AN:
34238
Middle Eastern (MID)
AF:
AC:
1538
AN:
2538
European-Non Finnish (NFE)
AF:
AC:
183782
AN:
331836
Other (OTH)
AF:
AC:
17245
AN:
30564
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
7372
14743
22115
29486
36858
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.508 AC: 77265AN: 152024Hom.: 20730 Cov.: 32 AF XY: 0.514 AC XY: 38173AN XY: 74290 show subpopulations
GnomAD4 genome
AF:
AC:
77265
AN:
152024
Hom.:
Cov.:
32
AF XY:
AC XY:
38173
AN XY:
74290
show subpopulations
African (AFR)
AF:
AC:
14206
AN:
41464
American (AMR)
AF:
AC:
7988
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
2144
AN:
3470
East Asian (EAS)
AF:
AC:
4161
AN:
5152
South Asian (SAS)
AF:
AC:
3073
AN:
4814
European-Finnish (FIN)
AF:
AC:
6458
AN:
10560
Middle Eastern (MID)
AF:
AC:
193
AN:
294
European-Non Finnish (NFE)
AF:
AC:
37364
AN:
67988
Other (OTH)
AF:
AC:
1107
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1910
3820
5731
7641
9551
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2442
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 24, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mucopolysaccharidosis type 7 Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.